The coronavirus pandemic has exposed the vulnerability and weaknesses of already fragile global food systems, say the authors […]
The UK government must alter its current strategy for tackling covid-19 or face a further wave of infections […]
Around half of England’s population is now served by an ICS
The Phase III IKEMA trial hit its primary endpoint
The research funded will help inform policy decisions during the novel coronavirus pandemic
The selective RET kinase inhibitor was cleared under the regulator’s accelerated approval process
The groups will explore novel methods to characterise pluripotent stem cells for the manufacture of regenerative medicine products
With its megamerger with Allergan finally in the books, AbbVie is officially a colossus with a bustling drug […]
Regeneron has been at the forefront of the COVID-19 fight for months with partnered med Kevzara in clinical trials […]
